Quanergy to Demonstrate Groundbreaking LiDAR-Equipped Security Surveillance System at IFSEC
Quanergy Systems Inc., the leading provider of LiDAR sensors and smart sensing solutions, today announced that it will demonstrate a first-of-its-kind security solution for intruder detection and surveillance automation at IFSEC International, Europe’s premier security trade show. The demonstration will integrate Quanergy’s Q-GuardTM security technology with a PTZ (Pan-Tilt-Zoom) camera from Overview Ltd, and will take place at booth D1675 from June 20-22.
This demonstration will mark the first time Q-Guard, an intrusion detection and perimeter fencing system powered by a Quanergy LiDAR sensor, has been integrated with a PTZ camera, allowing for real-time detection, tracking, and counting using 3D point clouds and color video. The system uses LiDAR to quickly detect and classify a human intruding into a secure area, and follow that unique subject with a video security camera throughout a designated area.
"Current security systems are plagued by inefficiencies and expensive false alarms. By combining these two technologies, LiDAR and PTZ cameras, we have created a new, optimized security solution," said Dr. Louay Eldada, chief executive officer of Quanergy Systems. "With Quanergy’s Q-Guard and Overview's PTZ camera, the system can detect security breaches quickly and accurately, and will catch any intrusion. No other system on the market today provides this integrated capability.”
With a LiDAR-equipped security system, security professionals no longer need to monitor several cameras and TV screens at the same time — rather, they can be assured that the LiDAR sensor will detect intrusions into secure areas and automatically direct the camera specifically to the location in question. The system can also zoom, focus, and monitor specific zones of interest, with certain behaviors prompting it to track and record within a given space.
“We’re excited to work with Quanergy to demonstrate the integration of cutting-edge LiDAR and Overview’s advanced security cameras,” said Graham Jones, chief executive officer of Overview Ltd. “Our demonstration shows the potential of automated security services and their ability to empower businesses and individuals to more efficiently keep their property safe.”
In this integration, Quanergy will be merging its Q-Guard technology, comprising an M8 LiDAR sensor, with Overview Ltd’s Hydra Uno™ camera, which is designed for operation in harsh environments and possesses outstanding accuracy as well as ultra-smooth and rapid motion with continuous rotation in both pan and tilt. Q-Guard and Hydra can work both indoors and outdoors, and in any weather or lighting condition. The M8 LiDAR sensor provides a 360° field of view, high accuracy, fine resolution and has a maximum range exceeding 150 meters.
The Overview Hydra PTZ platform will be on display during IFSEC in the Overview booth, C700.
In addition to security, Quanergy’s LiDAR sensors have applications in more than 30 market verticals including transportation, aerial mapping, and industrial automation.
About Quanergy Systems, Inc.
Quanergy Systems, Inc. was founded in 2012 and builds on decades of experience of its team in the areas of optics, photonics, optoelectronics, artificial intelligence software, and control systems. Headquartered in Sunnyvale, California, in the heart of Silicon Valley, Quanergy offers the world’s leading LiDAR sensors and software for real-time capture and processing of 3D mapping data and object detection, tracking, and classification. In transportation, the data is utilized to greatly improve the accuracy and reliability of on-board driver safety systems and enhance them with perception, scenario analysis, and decision making capability for active control, as well as enable autonomous driving in the future. Quanergy’s LiDARs lead in all six key commercialization areas – price, performance, reliability, size, weight, power consumption. For more information, visit www.quanergy.com.
About Overview Ltd
Overview develops and supplies advanced camera positioning technology and specialist sensors to the OEM/ODM market. Overview develops innovative technology in order to drive commercial opportunity for their customers. Overview is a British company founded in 1985 and headquartered in South West London. Now employing approximately 45 highly skilled staff, Overview manufactures more than 75,000 camera positioning systems per year. The company has developed commercial dome cameras through to military rapid deployment three sensor systems.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170612005379/en/
Contact information
Quanergy Systems Inc.
Ann Gargiulo, +1-408-245-9500
Director
of Marketing Communications
media@quanergy.com
or
Overview
Ltd
Ian Cox, +44 20 8875 4065
Business Development Manager
ian.cox@overview.co.uk
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 23:30:00 EEST | Press release
CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to existing therapies. Gilteritinib (Xospata®; Astellas Pharma, peak annual sales projection: $1.5 billion) and Quizartinib (Vanflyta®; Daiichi Sankyo) are two FDA-approved FLT3 inhibitors, with the former approved only for relapsed/refractory AML and the latter approved o
IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 23:05:00 EEST | Press release
IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global freight industry. “Einride shares our belief that quantum computing will fundamentally reshape and improve how large industries such as transportation and logistics operate,” said Niccolo de Masi, CEO of IonQ. “This partnership is aimed at creating a powerful platform with u
CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 202520.5.2025 22:26:00 EEST | Press release
CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung cancer (NSCLC) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. NSCLC, which accounts for 80% of lung cancer, is the most common cause of cancer death worldwide. Epidermal growth factor receptor (EGFR)-activating mutations (Del19 or L858R) are major oncogenic drivers of NSCLC. EGFR-positive NSCLC accounts for approximately 30% of all diagnosed cases of NSCLC (a similar market size to PD-L1-positive NSCLC, which is addressed by the world’s top-selling drug, Keytruda®). The current standard of care for EGFR-positive NSCLC is comprised of 3rd-generation inhibitors, most notably Osimertinib (Tagrisso®), whose annual sales exceed $6 billion. Most patients treated by tyrosine kinase inhibitors (TKIs) will eventually develop
NielsenIQ's Chief Technology Officer Mohit Kapoor Named Executive of the Year at Global Tech & AI Awards for Leading NIQ’s AI-Driven Tech Transformation20.5.2025 22:24:00 EEST | Press release
NielsenIQ (NIQ) is proud to announce that Mohit Kapoor, Chief Technology Officer, was named Executive of the Year at the inaugural Global Tech & AI Awards. This honor recognizes Mohit's exceptional leadership and visionary contributions to the tech industry, particularly in the realm of AI-powered consumer intelligence. "I am deeply honored to receive the Executive of the Year award at the Global Tech & AI Awards. This recognition is a testament to the incredible work and dedication of the entire NielsenIQ team,” said Mohit Kapoor, Chief Technology Officer, NIQ. “Together, we have redefined consumer and retail intelligence, leveraging AI to deliver unparalleled insights and drive meaningful change in the industry." Under Mohit's leadership, NIQ has adopted an AI-powered approach to its ambitious digital transformation which included a $400 million technology investment and the migration of its global client base onto Discover– a unified, cloud-based platform that seamlessly integrates
Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco20.5.2025 22:08:00 EEST | Press release
As part of the implementation of the commitments made in the joint declaration between His Majesty King Mohammed VI, may God Assist Him, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, TAQA Morocco, in partnership with Nareva and the Mohammed VI Fund for Investment, has signed three memorandums of understanding and related development agreements with the Government of Morocco and ONEE. These agreements cover the development of structuring projects in the power, water and renewable energy sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520313620/en/ Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco (Photo: AETOSWire) The program aims to strengthen the Kingdom's water and energy sovereignty through the development of flexible natural gas-based power generation capacit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom